Literature DB >> 19212112

Predictive models in colorectal liver metastases--can we personalize treatment and outcome?

Fenella K S Welsh1, Paris P Tekkis, Timothy G John, Myrddin Rees.   

Abstract

BACKGROUND/AIMS: Hepatic resection for colorectal liver metastases offers patients the best chance of long-term survival. Survival rates after resection range from 25 to 60%. Predictive models may risk-stratify patients and allow improved selection for surgery or other therapies. This review aims to achieve consensus regarding the predictors of survival after hepatic resection for colorectal metastases and evaluate current predictive models of outcome.
METHODS: A comprehensive literature review of published studies with more than 500 patients describing models for predicting long-term survival in patients undergoing hepatic resection for colorectal metastases.
RESULTS: Five large predictive models have been published to date. The three predictive models developed from the largest series agree over the key independent predictors of poor long-term outcome for patients undergoing liver resection for colorectal metastases. All five models have individual shortcomings, and whilst three have been internally validated, two have been externally validated with conflicting results. The Basingstoke Predictive Index appears to be accurate and internally validated.
CONCLUSIONS: There is need within the international surgical oncology community for consensus regarding a predictive model to be universally adopted for risk-stratifying patients who may benefit from intensive surveillance and selection for adjuvant therapy and clinical trials. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19212112     DOI: 10.1159/000184731

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  5 in total

1.  The role of 18FDG PET/CT in the management of colorectal liver metastases.

Authors:  Alec H Engledow; James R A Skipworth; Farrokh Pakzad; Charles Imber; Peter J Ell; Ashley M Groves
Journal:  HPB (Oxford)       Date:  2011-11-14       Impact factor: 3.647

2.  Recurrence patterns after laparoscopic resection of colorectal liver metastases.

Authors:  Nicolas Tabchouri; Brice Gayet; Shinya Okumura; Gianfranco Donatelli; Marc Beaussier; Mostefa Bennamoun; Christophe Louvet; David Fuks
Journal:  Surg Endosc       Date:  2018-05-14       Impact factor: 4.584

3.  The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy.

Authors:  D Pereyra; B Rumpf; M Ammann; S F Perrodin; D Tamandl; C Haselmann; J Stift; C Brostjan; F Laengle; G Beldi; T Gruenberger; P Starlinger
Journal:  Ann Surg Oncol       Date:  2019-01-07       Impact factor: 5.344

4.  Novel methods for clinical risk stratification in patients with colorectal liver metastases.

Authors:  Ki-Yeol Kim; Nam Kyu Kim; In-Ho Cha; Joong Bae Ahn; Jin Sub Choi; Gi-Hong Choi; Joon Suk Lim; Kang Young Lee; Seung Hyuk Baik; Byung Soh Min; Hyuk Hur; Jae Kyung Roh; Sang Joon Shin
Journal:  Cancer Res Treat       Date:  2014-09-11       Impact factor: 4.679

Review 5.  Liver Resection for Non-Colorectal Liver Metastases - Standards and Extended Indications.

Authors:  Ulf Kulik; Frank Lehner; Hüseyin Bektas; Jürgen Klempnauer
Journal:  Viszeralmedizin       Date:  2015-11-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.